Product
Botulinum toxin A
Aliases
Botox
8 clinical trials
10 indications
Indication
RosaceaIndication
Facial FlushingIndication
Trigeminal NeuralgiaIndication
HyperhidrosisIndication
Compartment SyndromeIndication
Bite ForceIndication
Botulinum ToxinsIndication
Type AIndication
Plantar FasciitisIndication
Complex Regional Pain SyndromesClinical trial
Effects of Botulinum Toxin Type a Treatment on Clinical and Biophysical Parameters in Patients With Erythematotelangiectatic Rosacea: A Prospective, Randomized, Placebo-controlled, Double-masked StudyStatus: Completed, Estimated PCD: 2023-05-01
Clinical trial
Treatment of Facial Flushing With Botulinum Toxin A Injections: A Split-Face, Double-blinded, Randomized Control TrialStatus: Active (not recruiting), Estimated PCD: 2024-12-01
Clinical trial
Safety and Efficacy of Botulinum Toxin A in Patients With Trigeminal Neuralgia: a Double-blind, Randomized, Placebo-controlled, Parallel-group Trial and Investigation of Neuro-inflammatory Biomarkers as Predictors of EfficacyStatus: Recruiting, Estimated PCD: 2025-10-01
Clinical trial
Longevity of Microwave Thermolysis and Botulinum Toxin A for Treatment of Axillary Hyperhidrosis: a Randomized Intra-individual TrialStatus: Completed, Estimated PCD: 2022-10-17
Clinical trial
Treatment of Lower Leg Anterolateral Chronic Exertional Compartment Syndrome With Intra-muscular Botulinum Injections.Status: Not yet recruiting, Estimated PCD: 2023-10-01
Clinical trial
Muscle Weakness Duration Post-injection of a Single Dose of Botulinum Toxin in the Masseter Muscle Bilaterally: a One-year Non-randomized Controlled TrialStatus: Completed, Estimated PCD: 2022-01-10
Clinical trial
Botulinum Toxin A Versus Steroids for the Treatment of Chronic Plantar Fasciitis: a Randomized Controlled StudyStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Clinical Effect of Thoracic Sympathetic Ganglion Block With Botulinum Toxin Type A in Patients With Upper Extremity Complex Regional Pain Syndrome: A Prospective Randomized, Double-blind, and Comparative Clinical TrialStatus: Not yet recruiting, Estimated PCD: 2026-04-25